Call for Abstracts

Abstract Submission Period

December 5, 2025 (Friday) – February 6, 2026 (Friday) Noon

Presentation Formats

• Oral Presentation
  Digital presentations will be held at the conference venue.
• Poster Presentation
  Paper Posters will be exhibited and presented at the poster venue.

Abstract Submission Method

Abstract submissions will be accepted online only. Submissions by mail or FAX will not be accepted.
Please download the dedicated abstract submission form (Excel format), fill in all required information, and upload the completed form through the online submission form.
Please observe the deadline strictly for the preparation of the abstract book.
Please review the following instructions and proceed to the online submission form by clicking the "Click here for abstract submission" button at the bottom of this page.

Presentation Eligibility

• The presenting author must be the first author of the abstract.
• Presenters may submit and present abstracts regardless of BCLA or JCLS membership status.
• For presenters who are not members of the Japan Contact Lens Society (JCLS), a Non-member Presentation Fee of JPY 10,000 is required, provided that the first author’s institutional affiliation does not include any institution based in Japan.
• This fee must be paid at the time of online registration. Payment of this fee is mandatory in order to obtain presentation eligibility.
• Further details will be provided at the time of the acceptance notification.

Abstract Submission Process

Please note that the applicant = first author = presenter.

Step 1: Download the Abstract Submission Form

Download the dedicated abstract submission form (Excel format)from the link provided at the bottom of this page.

Step 2: Complete the Abstract Submission Form

Fill in all required information in the Excel form according to the instructions below:

1. Abstract Title
   Within 80 half-width characters (including spaces)
2. Short Title
   Within 30 half-width characters (including spaces)
3. Abstract Body
   Within 1,200 half-width characters (including spaces)
4. Author Information
   • First author (presenter) name, affiliation, and BCLA membership number
   • Co-authors' names and affiliations (up to 14 co-authors; 15 people including the first author)
   • Up to 15 affiliated institutions can be listed
5. Application Category

   Select one from the following: Application Categories

   01	CL design and materials (hardware and software)
   02	Keratoconus
   03	Corneal shape, CL for astigmatism
   04	Far and near/multifocal CL
   05	Orthokeratology
   06	Visual function (myopia prevention, sports, low vision)

   07	Disinfection and care
   08	Tears and eye drops
   09	CL-related eye complications
   10	Social issues and awareness-raising activities
   11	Other/New fields

6. Conflict of Interest
   Please describe whether there is a conflict of interest related to the content of this conference presentation. For details, please refer to the Japanese Ophthalmological Society website. Additionally, you will be required to disclose this on your slides (slide 2) during your presentation.
7. Ethics Review Committee Approval
   Indicate whether approval was obtained.
8. Informed Consent
   Indicate whether informed consent was obtained.
9. Animal Experiment Committee Approval
   Indicate whether approval was obtained (if applicable).

Step 3: Upload the Completed Form

Access the online submission form by clicking the "Click here for abstract submission" button at the bottom of this page, and upload your completed Excel file.
After successful submission, a confirmation email will be sent to your registered email address. Please confirm receipt.

Input Regulations

1. The abstract body must be written with the following sections in order: [Purpose], [Methods], [Results], and [Conclusion]. For case reports, technical or device innovations, etc., please change the section names appropriately (for example, for case reports: [Introduction], [Case], [Discussion], and [Conclusion] if necessary).
2. Full-width characters count as 1 character, and half-width characters count as 1/2 character. Direct input of alphabet characters is half-width alphanumeric, so it counts as 1/2 character. Tags such as <SUP> are not counted in the character count. Half-width katakana, circled numbers, Roman numerals, special characters, and other platform-dependent characters cannot be used. When entering text, please check the "Notes on Input" posted on the registration screen.
3. Describe methods and results concretely. Quantify what can be expressed numerically, and perform statistical analysis if possible.
4. Conclusions and discussions should be based on the stated results.
5. When describing bacteria with scientific names, please write them in italics.
   Example) Staphylococcus aureus, S. epidermidis, Corynebacterium spp.
6. In principle, abbreviations cannot be used. However, they can be used only if they appear three or more times in the title and body. When using abbreviations, write the full term (abbreviation) at the first occurrence, such as pars plana vitrectomy (PPV). If using abbreviations in the title or short title would exceed the character limit, abbreviations can be used even at first occurrence, but be sure to write the full term (abbreviation) at the first occurrence in the body.
7. Regarding an approval of the animal research and ethics committee, e.g. IACUC, please select whether you have obtained an approval of the committee or not necessary on the abstract submission form. This does not need to be stated in the abstract body.
8. On abstract submission form, please select whether you have obtained an approval of the ethics committee, e.g. IRB, or if it is not necessary.
9. If approval has been obtained, please also enter the approval number.
10. This does not need to be stated in the abstract text.
11. Regarding an approval of the animal research and ethics committee, e.g. IACUC, please select whether you have obtained an approval of the committee or not necessary on the abstract submission form.
12. If approval has been obtained, please also enter the approval number.
13. The author is not required to mention it in the abstract body.
14. On the abstract submission form, please select whether you have obtained an informed consent, if it is not necessary, or if the study has been conducted by opt-out (obtained / not applicable / opt-out).

Additional Notes

• Abstracts without stated results will be subject to rejection.
• Do not describe content in the conclusion that is not stated in the results.
• Abstracts that are like "previews" such as "plan to investigate" or "will discuss" will be subject to rejection.

Notes on Duplicate Presentations

Papers that have been or will be presented in other ophthalmology-related academic meetings in Japan cannot be accepted. However, the following categories of papers will be treated as exceptions: specialized presentations (symposium, educational seminar, etc.), and papers presented at international academic meetings (in case of presentation at an international meeting convened in Japan, acceptable only if presented in English).

Notification of Abstract Acceptance/Rejection and Presentation Date/Time

Notification of abstract acceptance/rejection and presentation date/time will be sent by email in March (planned).
The results will also be posted on this website. Please entrust the decision on abstract acceptance/rejection to the conference president.

Handling of Personal Information

The "name," "contact information," and "email address" provided during abstract registration for this conference will be used for inquiries and presentation notifications from the secretariat.
Additionally, "author names," "affiliations," "abstract titles," and "abstract body text" will be used for publication in the abstract book and on the website. They will not be used for any other purposes.
All registered information will be strictly managed with necessary security measures.

Download Abstract Submission Form

Click here for abstract submission

Contact Information

Congress Secretariat
The 68th Annual Meeting of the Japanese Contact Lens Society
Congress Corporation
TEL: 03-3510-3701   E-mail: jcls2026@congre.co.jp